BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28235427)

  • 1. Efficient T3P
    Kamath PR; Sunil D; Das S; Abdul Salam AA; Rao BS
    Chem Biol Interact; 2017 Apr; 268():53-67. PubMed ID: 28235427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
    Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
    Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisindole-oxadiazole hybrids, T3P
    Kamath PR; Joseph MM; Abdul Salam AA; Therakathinal ST; Sunil D; Biswas S; Pai KSR
    J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28724188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Promoted Green Synthesis, Docking Study of Indole Spliced Thiadiazole, α-amino Phosphonates as Anticancer Agents and Antityrosinase Agents.
    Nikalje AG; Gawhane PA; Tiwari SV; Sangshetti JN; Damale MG
    Anticancer Agents Med Chem; 2018; 18(9):1267-1280. PubMed ID: 29667556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential.
    Kamath PR; Sunil D; Ajees AA; Pai KS; Biswas S
    Eur J Med Chem; 2016 Sep; 120():134-47. PubMed ID: 27187865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Novel Triazolo-Thiadiazoles from Heterogeneous "Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors.
    Baburajeev CP; Dhananjaya Mohan C; Ananda H; Rangappa S; Fuchs JE; Jagadish S; Sivaraman Siveen K; Chinnathambi A; Ali Alharbi S; Zayed ME; Zhang J; Li F; Sethi G; Girish KS; Bender A; Basappa ; Rangappa KS
    Sci Rep; 2015 Sep; 5():14195. PubMed ID: 26388336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
    Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
    Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
    Kumar D; Maruthi Kumar N; Chang KH; Shah K
    Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety.
    Zhao PL; Duan AN; Zou M; Yang HK; You WW; Wu SG
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4471-4. PubMed ID: 22647723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity.
    Zhang L; Zhao J; Zhang B; Lu T; Chen Y
    Eur J Med Chem; 2018 Apr; 150():809-816. PubMed ID: 29602036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new facile and straightforward method for the synthesis of 4H-1,2,3-thiadiazolo[5,4-b]indoles and determination of their antiproliferative activity.
    Belskaya NP; Lugovik KI; Bakulev VA; Bauer J; Kitanovic I; Holenya P; Zakhartsev M; Wölfl S
    Eur J Med Chem; 2016 Jan; 108():245-257. PubMed ID: 26686930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
    Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
    Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
    Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
    Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
    BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
    Kumar S; Gopalakrishnan V; Hegde M; Rana V; Dhepe SS; Ramareddy SA; Leoni A; Locatelli A; Morigi R; Rambaldi M; Srivastava M; Raghavan SC; Karki SS
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4682-4688. PubMed ID: 25205189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
    Mohamed MF; Hassaneen HM; Abdelhamid IA
    Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents.
    Hamdy R; Jones AT; El-Sadek M; Hamoda AM; Shakartalla SB; Al Shareef ZM; Soliman SSM; Westwell AD
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents.
    Altıntop MD; Sever B; Özdemir A; Ilgın S; Atlı Ö; Turan-Zitouni G; Kaplancıklı ZA
    Anticancer Agents Med Chem; 2018; 18(11):1606-1616. PubMed ID: 29745341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole.
    Wu J; Li J; Xu MH; Liu D
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3050-6. PubMed ID: 24880902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.